Print this pageCancer Institute NSW Board
There are currently eleven members of the Cancer Institute NSW Board.
Professor David Currow BMed MPH FRACP
Chief Cancer Officer and CEO
Professor David Currow is Chief Cancer Officer and CEO of the Cancer Institute NSW. Prior to this he was the foundation Chief Executive Officer of Cancer Australia, the Australian Government’s national cancer control agency. Professor Currow initially trained as a physician in internal medicine with sub-speciality training in palliative medicine and he completed a Master of Public Health exploring changes in the reported incidence of cancer unknown primary in New South Wales over a 25 year time period.
Former roles include foundation Director of the Nepean Cancer Care Centre, Sydney and Area Director of Palliative Services Wentworth Area Health Service, Sydney. Since 2000 he has held the Chair of Palliative and Supportive Services at Flinders University. He has published widely in palliative care journals and the general medical literature. He is a former president of the Clinical Oncological Society of Australia and a former president of Palliative Care Australia, the peak body for palliative care in the country.
The Hon Morris Iemma BEc LLB
Chairperson of the Board of the Cancer Institute NSW
Mr Iemma served as a Member of Parliament in the NSW Legislative Assembly for 17 years 3 months from May 1991 until September 2008. He held a number of Ministerial portfolios including Premier, Treasurer, Minister for Health, Minister for Sport and Recreation, Minister for Public Works and Services, Minister for State Development and Minister Assisting the Premier on Citizenship. He has a BEc degree from the University of Sydney and an LLB from the University of Technology Sydney.
Professor Robyn Ward MBBS PhD FRACP
Professor Ward is Professor of Medicine at Prince of Wales Hospital Sydney and Senior Staff Specialist in Medical Oncology and Family Cancer Services at St Vincent’s Hospital. She has been active in cancer research in Australia since 1991 and over that time has established and maintained an independent and highly successful biomedical and translational research group based at St. Vincent’s Hospital, Sydney. She has achieved a significant record of scholarship, research and academic leadership in translational and clinical cancer research. Her work has been continuously funded by peer reviewed grants, and has also attracted considerable commercial funding. She has authored 110 papers published in international peer reviewed research journals. She serves on a range of substantive committees at both the federal and state levels, including the Commonwealth government’s Pharmaceutical Benefits Advisory Committee (2000-present) and the Research Advisory Committees of the Cancer Institute NSW and the Cancer Council NSW.
Mr Keith Cox NP OAM
Mr Cox is a nurse practitioner in the oncology chemotherapy unit at Sydney's Royal Prince Alfred Hospital (RPA). He was authorised as a nurse practitioner in 2005 and prior to this he acted in a clinical nurse consultant role. Mr Cox has travelled to Nepal and New Guinea to help set up oncology units and to train local nurses. He is also a member of the Cancer Nursing Society of Australia and Chair of their Winter Congress Committee. Mr Cox is an honorary consultant at the University of Sydney and has tutored in chemotherapy at The Australian College of Nursing. He also works in other community areas including CanTeen, St Vincent de Paul and volunteering through his local parish. He was awarded an OAM in 2007 for his services to nursing and community volunteer work.
Ms Liza Carver BEc, LLB LLM
Ms Carver is a Partner in the law firm, Gilbert + Tobin, and is a Commissioner of the Australian Energy Market Commission. She is a former Non-Executive Director of RailCorp NSW, a former Non-Executive Director of the Rail Infrastructure Corporation, a former Non-Executive Director of State Rail Authority of NSW, a former Non-Executive Director of Rail Access Corporation and has served as an Associate Commissioner with the Australian Competition and Consumer Commission, a member of the NSW Independent Pricing and Regulatory Tribunal, and a member of the NSW Premier’s Council for Women between 1995 and 1999.
Dr Patrick Cregan MBBS, FRACS
Nepean Hospital Specialist Cancer Surgeon
Dr Cregan is a specialist surgeon with a major interest in breast, endocrine & endoscopic surgery based at Nepean Hospital. He has a particular interest in surgical robotics, having performed Australia's first and the world's sixth Telesurgical procedure.
Other interests include research interest in mathematical modelling of cancer, patient communication and the application of advanced technologies.
Dr Cregan has served on a number of committees/boards including the Royal Australian College of Surgeons, Wentworth Area Health Service, NSW Health Clinical Council and the Australasian Medical Simulation Society. Dr Cregan is currently the Chairman of the Board of a private Medical Technology and Research Company, Medicvision.
Professor Peter Gunning BSc(Hons), PhD
Professor Peter Gunning is the Head of the Oncology Research Unit in the Department of Pharmacology at the University of New South Wales. His research is focussed on the development of new therapeutic strategies for the treatment of childhood cancer. These strategies target the skeleton of the cancer cell and build on the principles of cell architecture that Professor Gunning's group has discovered over the last 20 years. Professor Gunning has published over 100 primary research articles and has recently edited the first book devoted to his field of research. Previous appointments have included leadership roles as Chair of the Division of Research at The Children’s Hospital at Westmead, Chair of the Westmead Research Hub Executive and Chair, Board of Bio-Link, a company established by the NSW Government to support commercialisation of biomedical intellectual property.
Dr Paul Moy BA (Hons-Ec), Dip Ed, PhD(Ec)
Global Head of Infrastructure and Global Chief Investment Officer, UBS Global Asset Management
Paul Moy is Global Head of Infrastructure, UBS Global Asset Management, based in London and has 21 years of investment industry experience. Paul is responsible for managing the business that originates and manages direct investments in infrastructure. In addition, he is Global Chief Investment Officer, responsible for the global investment activities of the business. Paul brings extensive principal investment, investment banking and advisory experience in the infrastructure sector, specifically relating to electricity generation, transmission and distribution, gas, water, toll roads, ports, rail, telecommunications and waste management.
Paul has extensive experience of public policy issues associated with infrastructure reform in Australia and, as Deputy Secretary of the NSW Treasury, was responsible for infrastructure reforms and privatisation. He was also a member of the National Competition Council and a Chairman or member of a number of public inquiries into infrastructure reform in Australia.
Dr Tony Hobbs MBBS DRANZCOG Dip.Child Health Dip.Tropical Medicine and Hygiene FACRRM GAICD
Dr Hobbs is a Rural GP obstetrician based in Cootamundra, NSW. He chaired the external Reference Group developing Australia’s first National Primary Health Care Strategy. He is the immediate past chair of the Australian General Practice Network and the current chair of the Riverina Division of General Practice and Primary Health. Dr Hobbs has a strong interest in Primary Health Care reform and has been involved in developing an innovative integrated Primary Health Care Centre in Cootamundra.
Mr John Stubbs BA Dip Acct
Mr Stubbs is the Executive Officer of Cancer Voices Australia and Manager of the NSW Bone Marrow Transplant Network. Mr Stubbs is a survivor of Leukaemia and an active representative of cancer consumers. He has served on the ANZ Clinical Trials Advisory Committee, the Radiation Oncology Jurisdictional Implementation Group (ROJIG) and the Therapeutic Goods Committee under the Department of Health and Ageing and the Australian Leukaemia Lymphoma Group Clinical Trials Data Monitoring Committee. He has also served on the Complementary Therapies Committee of the Cancer Institute NSW.
Ms Lucy Turnbull LLB MBA
Ms Turnbull was Lord Mayor of the City of Sydney from 2003 to 2004 and Deputy Lord Mayor from 1999 to 2003. She served as an Administrator of Tweed Shire Council until the Council elections in September 2008. She currently chairs a number of companies, both private and public, including WebCentral Group Limited, and Pengana Holdings Limited. She is a former chair of the NSW Government’s Ministerial Advisory Committee on Biotechnology and also served on the NSW Government’s Information Industry Business Advisory Board. She has served as a Director of the Sydney Cancer Foundation and as president of the Sydney Children's Hospital Foundation. She is currently a Board member of the Waterloo Redfern Authority.
